2 Apr

Newmont Stock Will Take Cues from Its Goldcorp Merger Execution

WRITTEN BY Anuradha Garg

Newmont’s underperformance

Newmont Mining (NEM) stock returned 3.2% in the first quarter, almost half the gains in the VanEck Vectors Gold Miners ETF (GDX) in the same period. It also underperformed its peers (NUGT) Goldcorp (GG), Agnico Eagle Mines (AEM), and Yamana Gold (AUY).

Newmont Stock Will Take Cues from Its Goldcorp Merger Execution


Newmont underperformed during the first quarter despite its earnings beat in its fourth-quarter results. Its EPS of $0.40 beat the consensus estimate by $0.16. Its revenue of $2.05 billion also beat the estimate by 9.0%.

Investors’ take on the NEM-GG merger

As we highlighted in Could the Newmont-Goldcorp Merger Form ‘The Go-To Gold Equity,’ investors weren’t happy with Newmont’s offer of a 17% premium on Goldcorp stock, which has been struggling to meet market expectations for over a year. Investors may see the deal as better for Goldcorp than Newmont. They may also be comparing this purchase price with Barrick Gold (GOLD) and Randgold Resources’ recent no-premium deal.

Future price action

While analysts and investors were unhappy with NEM’s offering a premium to Goldcorp, the combined company’s future price action will depend on how NEM is able to justify the premium through the execution of the merger. NEM will also need to assure investors that it can turn Goldcorp’s weaker assets around or sell them for a reasonable price.

Most of the obstacles for Newmont in terms of its Goldcorp merger seem to be in the rearview. Check out Will Newmont Investors Approve GG Merger after Special Dividend? for details on the merger’s timeline and recent developments.

Latest articles

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

In the November 14 trading session, Aurora Cannabis (ACB) stock fell 12.7% from the previous session during after-hours trading.

Strategy Analytics reported that Apple could lead the 5G smartphone market in 2020, outshining Samsung—the current leader in the global 5G market.

This week has been tough for the cannabis sector. Cronos Group and Canopy Growth reported lower-than-expected earnings, and the sector ETFs dropped.

Yesterday, Argus Research upgraded Uber stock from “hold” to “buy.” Let's look at Uber and Lyft’s recent analyst rating changes.